This GLP-1 (also written as GLP-one or GLP 1) companion supplement addresses the specific nutritional gaps created by GLP-1 receptor agonist medications (such as Ozempic, Wegovy, Mounjaro, and Zepbound). GLP-1 medications work partly by suppressing appetite and slowing gastric emptying. That's the mechanism behind the weight loss. But less food in means fewer vitamins and minerals in and the research now shows this isn't a theoretical concern. Butsch et al. (2025), the largest of the six studies in the Urbina review, tracked 461,382 GLP-1 users and found 22.4% had a new nutritional deficiency diagnosis within 12 months. Vitamin D was most common (13.6%), followed by nutritional anemia (4%), iron deficiency (3.2%), and B vitamin deficiency (2.6%). In a smaller dietary study (Johnson et al. 2025, Frontiers in Nutrition), 64% of GLP-1 users didn't meet iron intake recommendations, and 72% fell short on calcium.* This GLP-1 supplement covers the five most at-risk nutrients with bioavailable forms: methylcobalamin B12, chelated iron, chelated zinc, 5-MTHF folate, and vitamin D3

Eligibility criteria for Blue Cross Blue Shield coverage for therapy To access therapy through BCBS, you generally need to have an active BCBS insurance plan, choose an in-network licensed provider, and, in many cases, have a formal mental health diagnosis
For weight management, NHS access to semaglutide (Wegovy) is limited to specialist weight management services with restricted eligibility criteria and regional variation in availability
Escitalopram (Cipralex) is an SSRI that selectively inhibits the reuptake of serotonin in the brain